FDA-DMF-Filings-in-2019
X
amri-m-2020-01-27

nextFEATURED COMPANIESprevious

OUR PARTNER COMPANIES

nextNEWS & ALERTSprevious

TOP 10 NEWS OF THE DAY

NEWS LIBRARY

nextMARKET PLACEprevious

LATEST ENQUIRIES

nextBLOG & ANALYSISprevious

BLOG #phispers #pharmaflow
Post an enquiry PharmaCompass.com

Cipla in FDA trouble; FDA-backed cannabis drug posts strong sales in launch year

This week, Phispers brings you an update on the mysterious respiratory infection as over 500 people ...

Radio Compass

PharmaCompass.com

DMF submissions in 2019: India maintains bulk drug supply supremacy to US

At PharmaCompass, we highlighted the significance of India in the global active pharmaceutical ingr...

Radio Compass

PharmaCompass.com

US generic drug supply chain continues to shrink

The number of facilities registered with the US Food and Drug Administration (FDA) to supply gener...

Radio Compass

PharmaCompass.com

previousINTERVIEWS

“Post sartan and ranitidine recalls, drugmakers need out-of-box thinking to address API supply issues”

Last year, we had interviewed Paarul Oza to understand the challenges being faced by the API (activ...

PharmaCompass.com

“Oncomed is on its way to becoming the top CDMO, providing end-to-end solutions”

This week, SpeakPharma speaks to Aleš Šima, Head of Business Development Department at...

PharmaCompass.com

"Our drug delivery system innovations seek to improve patient adherence"

This week, Sunil Kumar Nataraj, technical manager at DFE Pharma, USA and Canada, shares some of the ...

PharmaCompass.com

"Our PCF technology allows us a minimal environmental footprint while ensuring a sustainable supply of drugs"

This week, SpeakPharma interviews Jackie Labbe, Vice-President, Sales & Marketing, Phyton Biot...

PharmaCompass.com

“Through our technological knowhow, we are able to reduce time to market for our clients”

This week, Speakpharma interviews David Lescuyer, President of Skyepharma, near Lyon in France, an o...

PharmaCompass.com

"Our quality intelligence helps us keep up with rapidly evolving regulatory landscape"

This week, SpeakPharma speaks to Stuart Needleman, Chief Commercial Officer, Piramal Pharma Solution...

PharmaCompass.com